Variable | Total (No.) (%) | Unruptured (No.) (%) | Ruptured (No.) (%) | P Value |
---|---|---|---|---|
Clinical outcomes | ||||
Total treatments | 93 | 81 (87) | 12 (13) | |
Mortality | 0 | 0 (0) | 0 (0) | 1.000 |
Morbidity | 4 (4) | 3 (3) | 1 (8) | .430 |
Infarction | 3 (3) | 2 (2) | 1 (8) | .343 |
Hydrocephalus | 1 (1) | 1 (1) | 0 (0) | 1.000 |
Visual outcomes | ||||
Total patients | 65 | 54 (83) | 11 (17) | |
Visual disturbance at presentation | 22 (34) | 21 (39) | 1 (9) | .082 |
Visual disturbance after treatment | .03 | |||
Improved | 15 (68) | 15 (71) | 0 (0) | |
Unchanged | 5 (22) | 4 (27) | 1 (100) | |
Worse | 2 (9) | 2 (9) | 0 (0) | |
New (% of all patients) | 1 (2) | 0 (0) | 1 (9) | |
Imaging outcomes | ||||
Aneurysms | 65 | 53 (82) | 12 (18) | |
Primary occlusion | 35 (55) | 30 (58) | 5 (42) | .523 |
Aneurysms with >12 months' follow-up | 53 | 45 | 8 | .211 |
Retreatment | 16 (30) | 10 (22) | 6 (75) | .0007a |
Progressive occlusion | 2 (4) | 2 (4) | 0 (0) | |
Unchanged | 34 (64) | 33 (73) | 2 (25) |
↵a Retreatment-versus-progressive occlusion/unchanged.